Literature DB >> 10612007

Costs of palliative care in the community, in hospitals and in hospices in the UK.

D Coyle1, N Small, A Ashworth, S Hennessy, S Jenkins-Clarke, R Mannion, N Rice, S Ahmedzai.   

Abstract

Mesh：

Year:  1999        PMID： 10612007     DOI： 10.1016/s1040-8428(99)00023-2

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Predictors of home care expenditures and death at home for cancer patients in an integrated comprehensive palliative home care pilot program.

Authors:  Doris M Howell; Tom Abernathy; Rhonda Cockerill; Kevin Brazil; Frank Wagner; Larry Librach
Journal:  Healthc Policy       Date:  2011-02

2.  Hospital costs of colorectal cancer care.

Authors:  D A L Macafee; J West; J H Scholefield; D K Whynes
Journal:  Clin Med Oncol       Date:  2009-03-20

3.  Treated Colorectal Cancer: What is the Cost to Primary Care?

Authors:  D A L Macafee; J West; J H Scholefield; D K Whynes
Journal:  Clin Med Oncol       Date:  2008-12-22

Review 4.  Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Nasuh C Büyükkaramikli; Hedwig M Blommestein; Rob Riemsma; Nigel Armstrong; Fiona J Clay; Janine Ross; Gill Worthy; Johan Severens; Jos Kleijnen; Maiwenn J Al
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

5.  Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.

Authors:  R Mansel; G Locker; L Fallowfield; A Benedict; D Jones
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

Review 6.  What cost components are relevant for economic evaluations of palliative care, and what approaches are used to measure these costs? A systematic review.

Authors:  Clare Gardiner; Christine Ingleton; Tony Ryan; Sue Ward; Merryn Gott
Journal:  Palliat Med       Date:  2016-09-27       Impact factor: 4.762
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.